Anti-tumor efficacy and pre-clinical immunogenicity of IFN alpha 2a-NGR

CORC > 兰州大学 > 兰州大学 > 基础医学院 > 期刊论文

	Anti-tumor efficacy and pre-clinical immunogenicity of IFN alpha 2a-NGR
	Zhang, BL; Gao, B; Dong, SH; Zhang, YQ; Wu, YJ
刊名	REGULATORY TOXICOLOGY AND PHARMACOLOGY
	2011-06
卷号	60 期号:1 页码:73-78
关键词	Anti-tumor activity rhIFN alpha 2a-NGR Immunogenicity Antibodies Binding Neutralizing
ISSN号	0273-2300
通讯作者	Wu, YJ (reprint author), Lanzhou Univ, Dept Pharmacol, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.
学科主题	Legal Medicine; Pharmacology & Pharmacy; Toxicology
收录类别	SCIE ; PUBMED ; MEDLINE ; BIOSIS
出版地	SAN DIEGO
语种	英语
WOS记录号	WOS:000291376700006
内容类型	期刊论文
源URL	[http://ir.lzu.edu.cn/handle/262010/121487]
专题	基础医学院_期刊论文
推荐引用方式 GB/T 7714	Zhang, BL,Gao, B,Dong, SH,et al. Anti-tumor efficacy and pre-clinical immunogenicity of IFN alpha 2a-NGR[J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY,2011,60(1):73-78.
APA	Zhang, BL,Gao, B,Dong, SH,Zhang, YQ,&Wu, YJ.(2011).Anti-tumor efficacy and pre-clinical immunogenicity of IFN alpha 2a-NGR.REGULATORY TOXICOLOGY AND PHARMACOLOGY,60(1),73-78.
MLA	Zhang, BL,et al."Anti-tumor efficacy and pre-clinical immunogenicity of IFN alpha 2a-NGR".REGULATORY TOXICOLOGY AND PHARMACOLOGY 60.1(2011):73-78.